Better Understanding of Gene Editing Tools
|
Moores Member Alexis C. Komor, PhD, a pioneer in base editing, led a study that demonstrates how certain DNA repair proteins can influence the accuracy of gene-editing tools. By identifying which proteins interfere with or support precise edits, her team is helping to make gene editing safer and more reliable for future therapies. Learn More>>
|
Moores Member Selected for ASCO Leadership Program
|
Moores Member Soo Park, MD, has been selected for the 2025–2026 class of the American Society of Clinical Oncology (ASCO) Leadership Development Program: Education Scholars.
This year-long program, limited to only 12 oncology professionals nationwide, provides emerging leaders with the tools to advance cancer education and translate the latest research and treatment for trainees, colleagues, and the cancer care community.
Park’s selection is a testament to her leadership, dedication to medical education, and commitment to excellence in oncology. She will participate in national training sessions, contribute to ASCO’s educational initiatives, and return with enhanced strategies to strengthen the teaching and learning that takes place at Moores.
|
|
|
| Neuronal aging causes mislocalization of splicing proteins and unchecked cellular stress
|
Uri Manor, PhD (Cancer Biology and Signaling), Robert Signer, PhD (Hematologic Malignancies), and Gene W. Yeo, PhD, MBA (Structural and Functional Genomics)
|
|
|
| The MURANO study: Final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL
|
Thomas J. Kipps, MD, PhD (Hematologic Malignancies)
|
|
|
| Long-term outcomes and prognostic impact of residual cancer burden after intensified neoadjuvant therapy in high-risk prostate cancer
|
Rana R. McKay, MD (Solid Tumor Therapeutics)
|
|
|
FEATURED FUNDING OPPORTUNITIES
|
- Application Deadline: Monday, June 23, 2025, 5:00 p.m. PT
- Notice of Awards: September 1, 2025
- Funding Cycle: September 1, 2025 to August 31, 2026
- Budget: Up to $40,000 for 1 year
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
|
|
10397: Optimizing Antibody-Drug Conjugate Therapy Through Molecular Analysis for Therapy Choice (ADC MATCH)
PI: Sharon Choi, MD, PhD
NCT ID: NCT06311214
UCSD 812494: RAdiation Dose TAiloRing Guided by Enhanced Targeting (RADTARGET)
PI: Tyler Seibert, MD
NCT ID: N/A
|
|
|
COMMUNITY, OUTREACH AND ENGAGEMENT (COE) |
The Science Of . . . Podcast
|
In the latest special episode of The Science Of . . . Podcast, recorded at the La Jolla Institute, high school student hosts interviewed Moores Member Miguel Reina-Campos, PhD, and Anshuman Bhanja, PhD (Postdoctoral Fellow, Gutkind Lab), regarding their career paths and contributions to science and technology. This episode will be released soon. Meanwhile, listen to The Science Of . . . episodes from Season 2. Listen Now>>
|
The COE-led Cancer Health Equity Collaborative (CHEC) hosted a mixer at Moores, which brought together cancer researchers and community stakeholders to discuss community needs and community-engaged research. COE introduced Valuing Our Insights in Community Engagement (VOICE), a new program to foster collaboration between researchers and community members to advance cancer health equity. Subscribe to CHEC Newsletter>>
|
12th Annual Old School Event
|
COE joined forces with the San Diego County Black Infant Health Program and the San Diego Association of Black Social Workers to present this event that brought the community together for connection, celebration, family resources, food and support.
|
|
|
|
